Melanoma is one of the most common cancers diagnosed in pregnancy and has a high
metastatic potential. As the incidence of melanoma increases, careful clinical evaluation of …

Nodal status in melanoma is a critically important prognostic factor for patient outcome. The
survival rate drops to< 10% when melanoma has spread beyond the regional lymph nodes …

S100B protein detected in the serum of patients with cutaneous melanoma has been long
reported as a prognostic biomarker. However, no consensus exists on its implementation in …

Background Cutaneous melanoma (CM) is one of the most fatal types of skin cancer.
Alarmingly, increases in incidence and mortality were noted globally for this malignancy …

Melanoma is an aggressive cancer that is highly resistance to therapies once metastasized.
We studied microRNA (miRNA) expression in clinical melanoma subtypes and evaluated …

Study Aim: Cutaneous melanoma accounts for approximately 4% of all skin cancers
diagnosis each year in the USA but is responsible for 75% of skin cancer deaths. Physicians …

Background: We recently reported a steady increase in the incidence and mortality of
cutaneous malignant melanoma (CMM) in Canada during 1992-2010. Objectives: The …

Background: Melanoma is the most serious skin cancer. There is an established correlation
between thickness and aggressiveness of the tumor. Nevertheless, the potential value of …

Background: Over 90% of skin cancers including cutaneous melanoma (CM) are related
directly to sun exposure. Despite extensive knowledge on ultraviolet radiation's (UVR) …

Immunotherapy with immune checkpoint inhibitors, such as anti-PD-1 drugs, is an area in
increasing development for its efficacy and advantages in the treatment of advanced …